GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (OTCPK:CPHRF) » Definitions » Cyclically Adjusted FCF per Share

Cipher Pharmaceuticals (Cipher Pharmaceuticals) Cyclically Adjusted FCF per Share : $0.52 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Cipher Pharmaceuticals Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Cipher Pharmaceuticals's adjusted free cash flow per share for the three months ended in Dec. 2023 was $0.098. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.52 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Cipher Pharmaceuticals's average Cyclically Adjusted FCF Growth Rate was 11.30% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 13.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Cipher Pharmaceuticals was 81.70% per year. The lowest was 12.50% per year. And the median was 14.90% per year.

As of today (2024-04-27), Cipher Pharmaceuticals's current stock price is $6.23. Cipher Pharmaceuticals's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $0.52. Cipher Pharmaceuticals's Cyclically Adjusted Price-to-FCF of today is 11.98.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Cipher Pharmaceuticals was 220.33. The lowest was 1.00. And the median was 5.57.


Cipher Pharmaceuticals Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Cipher Pharmaceuticals's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipher Pharmaceuticals Cyclically Adjusted FCF per Share Chart

Cipher Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.36 0.45 0.45 0.52

Cipher Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.49 0.51 0.52 0.52

Competitive Comparison of Cipher Pharmaceuticals's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Cipher Pharmaceuticals's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipher Pharmaceuticals's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipher Pharmaceuticals's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Cipher Pharmaceuticals's Cyclically Adjusted Price-to-FCF falls into.



Cipher Pharmaceuticals Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cipher Pharmaceuticals's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.098/125.4675*125.4675
=0.098

Current CPI (Dec. 2023) = 125.4675.

Cipher Pharmaceuticals Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 0.348 98.604 0.443
201406 0.165 99.473 0.208
201409 0.243 99.394 0.307
201412 0.118 98.367 0.151
201503 -0.188 99.789 -0.236
201506 0.078 100.500 0.097
201509 0.070 100.421 0.087
201512 0.049 99.947 0.062
201603 0.080 101.054 0.099
201606 0.205 102.002 0.252
201609 0.185 101.765 0.228
201612 0.184 101.449 0.228
201703 0.042 102.634 0.051
201706 0.166 103.029 0.202
201709 0.269 103.345 0.327
201712 0.267 103.345 0.324
201803 0.113 105.004 0.135
201806 0.002 105.557 0.002
201809 0.011 105.636 0.013
201812 0.046 105.399 0.055
201903 0.013 106.979 0.015
201906 0.120 107.690 0.140
201909 0.071 107.611 0.083
201912 0.075 107.769 0.087
202003 0.172 107.927 0.200
202006 0.071 108.401 0.082
202009 -0.067 108.164 -0.078
202012 0.226 108.559 0.261
202103 0.159 110.298 0.181
202106 0.120 111.720 0.135
202109 0.019 112.905 0.021
202112 0.218 113.774 0.240
202203 0.074 117.646 0.079
202206 0.123 120.806 0.128
202209 0.165 120.648 0.172
202212 0.053 120.964 0.055
202303 0.183 122.702 0.187
202306 0.115 124.203 0.116
202309 0.232 125.230 0.232
202312 0.098 125.468 0.098

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Cipher Pharmaceuticals  (OTCPK:CPHRF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Cipher Pharmaceuticals's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=6.23/0.52
=11.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Cipher Pharmaceuticals was 220.33. The lowest was 1.00. And the median was 5.57.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Cipher Pharmaceuticals Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Cipher Pharmaceuticals's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cipher Pharmaceuticals (Cipher Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

Cipher Pharmaceuticals (Cipher Pharmaceuticals) Headlines